Mergers and Acquisitions

Mergers and Acquisitions Articles

Eli Lilly shares had a bit of a boost on Wednesday after it was announced that one of its subsidiaries would be acquiring Boehringer Ingelheim Vetmedica.
Generally speaking, a merger worth $6.5 billion is considered a fairly large merger. In this particular instance, it is likely that the public may have never heard of either company involved. Sorry,...
Janus Capital Group shares saw a handy gain in Monday’s session after it was announced that Janus had agreed to a merger of equals with Henderson Group.
Shares of Shopify saw a handy gain early on Monday after the company announced that it will be acquiring privately held Boltmade.
Cabela’s shares made a handy gain on Monday after it was announced that Bass Pro Shops would be acquiring the company.
Procter & Gamble announced that it had transferred its specialty beauty business to Coty, effectively completing its efforts to streamline and strengthen its product portfolio.
Cheniere Energy announced Friday morning that it has offered to acquire all publicly held shares of Cheniere Energy Partners LP Holdings that it does not already own.
Shares of Lexmark International jumped on the news that it received approval from the Committee on Foreign Investment in the United States for its Apex deal.
It would be the final blow to Yahoo if in the massive breach one of the email accounts hacked belonged to CEO Marissa Mayer.
National Amusements believes that a combination of CBS and Viacom might offer substantial synergies to better attack the changing entertainment and media landscape.
Shares of Chemtura saw a solid gain in Monday’s session after the company announced its acquisition by Lanxess.
Twitter may or may not be for sale. Salesforce.com may or may not be the buyer. If Salesforce does make an offer, its shares could drop 25%.
Shares of WCI Communities saw a handy gain after it was announced that Lennar would be acquiring the company.
A story in Wednesday's Financial Times that Apple is considering acquiring sports car and Formula One car maker McLaren seems a little out of whack. Really, who wants a self-driving, $1.15 million...
Eleven Biotherapeutics announced that it has entered into a definitive agreement to acquire Viventia and its lead product candidates Vicinium and Proxinium.